Advertisement

Topics

Ipsen Announces Co-Promotion Agreement With Saol Therapeutics To Promote Dysport® ...

04:06 EDT 30 Jun 2017 | BioMedReports - Blog

Saol sales team to promote Dysport® for select approved therapeutic indications in U.S. hospitals

Read more...

Original Article: Ipsen Announces Co-Promotion Agreement With Saol Therapeutics To Promote Dysport® ...

NEXT ARTICLE

More From BioPortfolio on "Ipsen Announces Co-Promotion Agreement With Saol Therapeutics To Promote Dysport® ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...